title: Role of adenosine in dialysis-induced hypotension.
abstract: First, this investigation showed that plasma levels of inosine, hypoxanthine, and xanthine, which are metabolites of adenosine, rose sharply when blood pressure dropped suddenly along with symptoms during a hemodialysis session (sudden hypotension), but not when it decreased gradually with eventual symptoms (gradual hypotension). Because adenosine has an action to dilate vessels, this result indicates the possibility that the increased release of adenosine would be a cause of sudden hypotension. Second, it was found that the frequency of sudden hypotension decreases with the administration of caffeine, which is an adenosine-receptor antagonist, whereas the frequency of gradual hypotension did not change. This result supports the above-mentioned hypothesis that adenosine may well be a mediator of sudden hypotension, but not of gradual hypotension. Third, our investigation demonstrated no significant differences in plasma norepinephrine level, in plasma renin activity, or in mean blood pressure between the hemodialysis session in which caffeine was administered and the session in which a placebo was given. These findings suggest that the effect of caffeine administration to prevent sudden hypotension is not mediated by the stimulation of the sympathetic nervous system or activation of the renin-angiotensin system, but by the adenosine-receptor antagonism.
authors.affiliation: Department of Internal Medicine, Branch Hospital, Nagoya University School of Medicine, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Shinzato
authors.forename: M
authors.initials: M
authors.lastname: Miwa
authors.forename: S
authors.initials: S
authors.lastname: Nakai
authors.forename: H
authors.initials: H
authors.lastname: Morita
authors.forename: H
authors.initials: H
authors.lastname: Odani
authors.forename: I
authors.initials: I
authors.lastname: Inoue
authors.forename: K
authors.initials: K
authors.lastname: Maeda
mesh_terms: D000241:Adenosine / Q000502:physiology*; D000368:Aged; D002110:Caffeine / Q000494:pharmacology; D005260:Female; D006801:Humans; D007022:Hypotension / Q000145:classification / Q000209:etiology* / Q000503:physiopathology; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000097:blood; D007288:Inosine / Q000097:blood; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D009638:Norepinephrine / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects*; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014655:Vascular Resistance / Q000502:physiology; D014664:Vasodilation / Q000502:physiology; D019820:Xanthine; D014970:Xanthines / Q000097:blood
chemical_list: D007042:Hypoxanthines; D014970:Xanthines; D019820:Xanthine; D019271:Hypoxanthine; D002110:Caffeine; D007288:Inosine; D000241:Adenosine; D009638:Norepinephrine